Attached files
| file | filename |
|---|---|
| 10-Q - FORM 10-Q - ORAGENICS INC | d937053d10q.htm |
| EX-10.5 - AMENDMENT NO. 1 TO THE LICENSE AGREEMENT - ORAGENICS INC | d937053dex105.htm |
| EX-31.1 - CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER - ORAGENICS INC | d937053dex311.htm |
| EX-31.2 - CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER - ORAGENICS INC | d937053dex312.htm |
| EX-32.1 - CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 - PRINCIPAL EXECUTIVE OFFICER - ORAGENICS INC | d937053dex321.htm |
| EX-10.6 - SECOND AMENDMENT TO LICENSE AGREEMENT - ORAGENICS INC | d937053dex106.htm |
Exhibit 32.2
Certification
Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350)
In connection with the Quarterly Report on Form 10-Q for the quarter ended June 30, 2015 (the “Report”) of Oragenics, Inc. (the “Registrant”), as filed with the Securities and Exchange Commission on the date hereof, I, Michael Sullivan, hereby certify, to the best of my knowledge, that:
(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.
| /s/ Michael Sullivan |
| Name: Michael Sullivan |
| Chief Financial Officer |
| (Principal Financial Officer) |
| Date: August 7, 2015 |